MaaT Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MAAT?
Owner TypeNumber of SharesOwnership Percentage
Institutions10,7100.0769%
Individual Insiders235,5651.69%
Private Companies3,261,88723.4%
General Public3,564,83625.6%
VC/PE Firms6,845,37149.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.2%.


Top Shareholders

Top 10 shareholders own 74.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.1%
Bpifrance Participations SA
2,802,439€23.1m0%0.17%
18.9%
Seventure Partners
2,630,568€21.7m0%50.94%
14.6%
Symbiosis LLC
2,027,702€16.7m0%no data
10.2%
Crédit Mutuel Innovation
1,412,364€11.6m0%28.55%
8.87%
BIOCODEX - Incubação de Empresas de Ciências da Vida, S.A.
1,234,185€10.2m0%no data
1.68%
Herve Affagard
233,605€1.9m0%no data
0.037%
Financiere Arbevel
5,162€42.5k0%0.01%
0.023%
Simplify Asset Management Inc.
3,151€26.0k31.5%no data
0.017%
Propel Bio Management, LLC
2,397€19.7k76%0.01%
0.014%
Karim Dabbagh
1,960€16.1k0%no data